globenewswire

VANCOUVER, British Columbia, Aug. 08, 2025 (GLOBE NEWSWIRE) -- Rubicon Organics Inc. (TSXV: ROMJ) (OTCQX: ROMJF) (“Rubicon Organics” or the “Company”), a licensed producer focused on cultivating and selling organic certified and premium cannabis products, will release its financial results for the three and six months ended June 30, 2025 (“Q2 2025”) before market open on Monday, August 18, 2025.

Shenzhen, China , Aug. 08, 2025 (GLOBE NEWSWIRE) -- On August 7, 2025, Beijing time, Lexin (NASDAQ: LX), China’s leading new-consumption digital technology service provider, today announced its unaudited financial results for the second quarter of 2025: revenue reached RMB 3.59 billion , up 15.6% quarter-over-quarter (QoQ); profit (Non-GAAP EBIT) was RMB 670 million , up 15.2% QoQ and 116.4% year-over-year (YoY). Q2 profit was the highest in 14 quarters, marking the fifth straight quarter of sequential growth, while multiple core business indicators continued to improve.

Discover the Benefits of Titanium Cutting Boards for Hygiene, Durability, and Food Safety

MIAMI, FL, Aug. 08, 2025 (GLOBE NEWSWIRE) -- MIAMI, FL – August 8, 2025 – Earth Science Tech, Inc. (OTC: ETST) (“ETST” or the “Company”), a strategic holding company focused on acquiring and scaling high-potential operating businesses, today announced its financial and operational results for the first fiscal quarter ended June 30, 2025.

Photo Courtesy of Lithios Beverages

Photo Courtesy of: ChatAndBuild

Management to host conference call on Monday, August 11, 2025, at 4:30 PM ET

Prize AI Technologies launched a $PRIZE token presale, raising $100K+ in the first week and targeting the $400B arcade/casino market. The platform integrates AI analytics with blockchain rewards through a consumer app and an operator dashboard. Stage 1 tokens are priced at $0.01 and have 33% APR staking yields.

TORONTO, Aug. 08, 2025 (GLOBE NEWSWIRE) -- Edesa Biotech, Inc. (Nasdaq:EDSA), a clinical-stage biopharmaceutical company focused on developing host-directed therapeutics for immuno-inflammatory diseases, today reported financial results for the three and nine months ended June 30, 2025 and provided an update on its business.

Singapore, Singapore, Aug. 08, 2025 (GLOBE NEWSWIRE) -- The JinGangShan Asia-Pacific General Association today announced the official launch of two landmark initiatives valued at a combined SGD $43 billion, with strategic developments on Bintan Island, Indonesia, and Penang Island, Malaysia. These flagship projects—the ultra-secure Bintan Citadel and the bi-national Life Memorial Services Park—mark a significant milestone in the Association’s mission to create the world’s foremost sanctuary for safeguarding human cultural heritage and wealth for generations to come.

CAMBRIDGE, Mass., Aug. 08, 2025 (GLOBE NEWSWIRE) -- Fulcrum Therapeutics, Inc.^® (Nasdaq: FULC), a clinical-stage biopharmaceutical company focused on developing small molecules to improve the lives of patients with genetically defined rare diseases, today announced that the company granted non-statutory stock options to new employees. Fulcrum granted stock options to purchase shares of the company’s common stock pursuant to the company’s 2022 Inducement Stock Incentive Plan, as amended, or the plan, as an inducement material to the new employees entering into employment with Fulcrum in accordance with Nasdaq Listing Rule 5635(c)(4).